Kite Pharma (KITE) Reports Q2 Loss of $2.27/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Form 8-K Kite Pharma, Inc. For: Aug 14
August 15, 2014 6:02 AM EDThttp://archive.fast-edgar.com/20140815/AD22B22FZC2RK9Z2222I2ZXOGQM9OZ223262 Filed on: August 15, 2014... More
Form 10-Q Kite Pharma, Inc. For: Jun 30
August 14, 2014 5:23 PM EDThttp://archive.fast-edgar.com/20140814/AFAZBG2CZ222KZ34222I2ZZ2GVM9ZY22ZZ62 Filed on: August 14, 2014... More
